# ZIAGEN® Post-marketing Surveillance

> **NCT01205243** · — · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 671 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus I

## Interventions

- **DRUG:** ZIAGEN®

## Key facts

- **NCT ID:** NCT01205243
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-01
- **Primary completion:** 2015-02-01
- **Final completion:** 2015-02-05
- **Target enrollment:** 671 (ACTUAL)
- **Last updated:** 2018-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01205243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01205243, "ZIAGEN® Post-marketing Surveillance". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01205243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*